| Rachel Michelle Applegate, MSN, FNP-BC | |
|
657 Hemlock St Ste 200, Macon, GA 31201-8324 | |
| (478) 733-4297 | |
| Not Available |
| Full Name | Rachel Michelle Applegate |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 657 Hemlock St Ste 200, Macon, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013579846 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | RN258212 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Houston Medical Center | Warner robins, GA | Hospital |
| Coliseum Northside Hospital | Macon, GA | Hospital |
| Coliseum Medical Centers, Llc, Dba | Macon, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cogent Healthcare Of Georgia Pc | 2961483607 | 255 |
| Cogent Healthcare Of Macon, Llc | 9234104019 | 52 |
News Archive
UT Southwestern Medical Center and California researchers today provide the first report that an enzyme previously known solely for its role in cell division also acts as an on-off switch in the innate immune system - the body's first defense against infection.
Inappropriate growth and survival signaling, which leads to the aberrant growth of cancer cells, is a driving force behind tumors. Much of current cancer research focuses on the kinase enzymes whose mutations are responsible for such disregulated signaling, and many successful molecularly targeted anti-cancer therapeutics are directed at inhibiting kinase activity.
Using doses of caffeine equivalent to drinking one to four cups of coffee and an intense arithmetic test as stressors, Klein and her colleagues found a rise in the amount of alpha amylase, an enzyme secreted by the salivary glands, in the healthy young men who participated in the study.
Australian researchers have developed a novel technique that tracks proteins "behaving badly" and may have found a way that leads to new treatments for brain disease. The team believes the discovery could help in the development of drugs to treat diseases such as Alzheimer's, Parkinson's and Huntington's.
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
› Verified 3 days ago
| Entity Name | Cogent Healthcare Of Georgia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609827823 PECOS PAC ID: 2961483607 Enrollment ID: O20040527000856 |
News Archive
UT Southwestern Medical Center and California researchers today provide the first report that an enzyme previously known solely for its role in cell division also acts as an on-off switch in the innate immune system - the body's first defense against infection.
Inappropriate growth and survival signaling, which leads to the aberrant growth of cancer cells, is a driving force behind tumors. Much of current cancer research focuses on the kinase enzymes whose mutations are responsible for such disregulated signaling, and many successful molecularly targeted anti-cancer therapeutics are directed at inhibiting kinase activity.
Using doses of caffeine equivalent to drinking one to four cups of coffee and an intense arithmetic test as stressors, Klein and her colleagues found a rise in the amount of alpha amylase, an enzyme secreted by the salivary glands, in the healthy young men who participated in the study.
Australian researchers have developed a novel technique that tracks proteins "behaving badly" and may have found a way that leads to new treatments for brain disease. The team believes the discovery could help in the development of drugs to treat diseases such as Alzheimer's, Parkinson's and Huntington's.
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
› Verified 3 days ago
| Entity Name | Cogent Healthcare Of Macon, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073564217 PECOS PAC ID: 9234104019 Enrollment ID: O20040826000927 |
News Archive
UT Southwestern Medical Center and California researchers today provide the first report that an enzyme previously known solely for its role in cell division also acts as an on-off switch in the innate immune system - the body's first defense against infection.
Inappropriate growth and survival signaling, which leads to the aberrant growth of cancer cells, is a driving force behind tumors. Much of current cancer research focuses on the kinase enzymes whose mutations are responsible for such disregulated signaling, and many successful molecularly targeted anti-cancer therapeutics are directed at inhibiting kinase activity.
Using doses of caffeine equivalent to drinking one to four cups of coffee and an intense arithmetic test as stressors, Klein and her colleagues found a rise in the amount of alpha amylase, an enzyme secreted by the salivary glands, in the healthy young men who participated in the study.
Australian researchers have developed a novel technique that tracks proteins "behaving badly" and may have found a way that leads to new treatments for brain disease. The team believes the discovery could help in the development of drugs to treat diseases such as Alzheimer's, Parkinson's and Huntington's.
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Michelle Applegate, MSN, FNP-BC 657 Hemlock St Ste 200, Macon, GA 31201-8324 Ph: (478) 733-4297 | Rachel Michelle Applegate, MSN, FNP-BC 657 Hemlock St Ste 200, Macon, GA 31201-8324 Ph: (478) 733-4297 |
News Archive
UT Southwestern Medical Center and California researchers today provide the first report that an enzyme previously known solely for its role in cell division also acts as an on-off switch in the innate immune system - the body's first defense against infection.
Inappropriate growth and survival signaling, which leads to the aberrant growth of cancer cells, is a driving force behind tumors. Much of current cancer research focuses on the kinase enzymes whose mutations are responsible for such disregulated signaling, and many successful molecularly targeted anti-cancer therapeutics are directed at inhibiting kinase activity.
Using doses of caffeine equivalent to drinking one to four cups of coffee and an intense arithmetic test as stressors, Klein and her colleagues found a rise in the amount of alpha amylase, an enzyme secreted by the salivary glands, in the healthy young men who participated in the study.
Australian researchers have developed a novel technique that tracks proteins "behaving badly" and may have found a way that leads to new treatments for brain disease. The team believes the discovery could help in the development of drugs to treat diseases such as Alzheimer's, Parkinson's and Huntington's.
NicOx S.A. today announced that it has received a filing communication from the U.S. Food and Drug Administration (FDA) stating that the New Drug Application (NDA) for naproxcinod is accepted for filing. NicOx submitted the NDA on September 24th, seeking approval for the relief of the signs and symptoms of osteoarthritis.
› Verified 3 days ago
Michelle Renee Brown, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 655 1st St, Macon, GA 31201 Phone: 478-301-5930 Fax: 478-301-5932 | |
Mrs. Jamie Lynn Harrelson, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4061 Vineville Ave, Macon, GA 31210 Phone: 478-757-7345 | |
Skylar Nelson, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 330 Hospital Dr Ste 200, Macon, GA 31217 Phone: 478-745-1191 | |
Jo Beth Roberts, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 777 Hemlock St, Macon, GA 31201 Phone: 478-633-6706 Fax: 478-633-5384 | |
Jennifer Johnson Slade, CPNP-PC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3888 Northside Dr, Macon, GA 31210 Phone: 478-477-4044 Fax: 478-477-7076 | |
Mrs. Lynn Davis Waits, MSN, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 100 College Station Dr, Macon, GA 31206 Phone: 478-471-2092 | |
Ms. Mirela Danaj, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 777 Hemlock Street Msc #104, Macon, GA 31201 Phone: 478-633-7550 |